Interaction of Glia Activation and Neurotransmission in Hippocampus of Neuropathic Rats Treated With Mirtazapine

Experimental and Clinical Psychopharmacology

Volumn 17, Issue 3, 2009, Pages 198-203

  Zhu, Juan ^a   Wei, Xiaowei ^a   Liu, Jian ^a   Hu, Yifeng ^a   Xu, Jianguo ^a  

^a JINLING HOSPITAL   (China)

Author keywords

GFAP; mirtazapine; neuropathic pain; neurotransmitter; pro inflammatory cytokines

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 1BETA; MIRTAZAPINE; TUMOR NECROSIS FACTOR ALPHA;

ADRENERGIC SYSTEM; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; ASTROCYTE; CHRONIC PAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG MECHANISM; GLIA; HIPPOCAMPUS; HYPERALGESIA; MALE; NEUROPATHIC PAIN; NEUROTRANSMISSION; NONHUMAN; RAT; SEROTONINERGIC SYSTEM;

ANALGESICS; ANIMALS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ASTROCYTES; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; HYPERALGESIA; INTERLEUKIN-1BETA; MALE; MIANSERIN; NEUROGLIA; RATS; RATS, SPRAGUE-DAWLEY; SYNAPTIC TRANSMISSION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67650363769     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0016033     Document Type: Article

References (41)

1. Araque A., Parpura V., Sanzgiri R.P., and Haydon P.G. Glutamate-dependent astrocyte modulation of synaptic transmission between cultured hippocampal neurons. European Journal of Neuroscience 10 (1998) 2129-2142
2. Covey W.C., Ignatowski T.A., Knight P.R., and Spengler R.N. Brain-derived TNFα: Involvement in neuroplastic changes implicated in the conscious perception of persistent pain. Brain Research 859 (2000) 113-122
3. Covey W.C., Ignatowski T.A., Renauld A.E., Knight P.R., Nader N.D., and Spengler R.N. Expression of neuron-associated tumor necrosis factor alpha in the brain is increased during persistent pain. Regional Anesthesia and Pain Medicine 27 (2002) 357-366
4. Cunha J.M., Cunha F.Q., Poole S., and Ferreira S.H. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. British Journal of Pharmacology 130 (2000) 1418-1424
5. De Boer T. The effects of mirtazapine on central noradrenergic and serotonergic neurotransmission. International Clinical Psychopharmacology 10 Suppl. 4 (1996) 19-23
6. De Boer T., Maur G., Raitieri M., De Vos C.J., Wieringa J., and Pinder R.M. Neurochemical and autonomic profiles of the 6-aza-analogue of mianserin, org 3770 and its enantiomers. Neuropharmacology 27 (1988) 399-408
7. DeLeo J.A., Tawfik V.L., and LaCroix-Fralish M.L. The tetrapartite synapse: Path to CNS sensitization and chronic pain. Pain 122 (2006) 17-21
8. DeLeo J.A., and Winkelstein B.A. Physiology of chronic spinal pain syndromes: From animal models to biomechanics. Spine 27 (2002) 2526-2537
9. Duman R.S., Heninger G.R., and Nestler E.J. A molecular and cellular theory of depression. Archives of General Psychiatry 54 (1997) 597-606
10. Falchi M., Ferrara F., Gharib C., and Dib B. Hyperalgesic effect of intrathecally administered interleukin-1 in rats. Drugs Under Experimental and Clinical Research 27 3 (2001) 97-101
11. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
12. Hauser C.J. Regional macrophage activation after injury and the compartmentalization of inflammation in trauma. New Horiz 4 (1996) 235-251
13. Haydon P.G. Glia: Listening and talking to the synapse. Nature Reviews Neuroscience 2 (2001) 185-193
14. Holm K., and Markham A. Mirtazapine: A review of its use in major depression. Drugs 57 (1999) 607-631
15. Ignatowski T.A., Covey W.C., Knight P.R., Severin C.M., Nickola T.J., and Spengler R.N. Brain-derived TNF alpha mediates neuropathic pain. Brain Research 841 (1999) 70-77
16. Ignatowski T.A., and Spengler R.N. Tumor necrosis factor-a: Presynaptic sensitivity is modified after antidepressant drug administration. Brain Research 665 (1994) 293-299
17. Ignatowski T.A., Sud R., Reynolds J.L., Knight P.R., and Spengler R.N. The dissipation of neuropathic pain paradoxically involves the presence of tumor necrosis factor-α (TNF). Neuropharmacology 48 (2005) 446-448
18. Jorgen Bengtsson H., Kele J., Johansson J., and Hjorth S. Interaction of the antidepressant mirtazapine with α2-adrenoceptors modulating the release of 5-HT in different rat brain regions in vivo, Naunyn-Schmiedeberg's arch. Pharmacology 362 (2000) 406-412
19. Kim S.H., and Chung J.M. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50 (1992) 355-363
20. Korzeniewska-Rybicka I., and Plaznik A. Analgesic effect of antidepressant drugs. Pharmacology, Biochemistry and Behavior 59 (1998) 331-338
21. Laughlin T.M., Bethea J.R., Yezierski R.P., and Wilcox G.L. Cytokine involvement in dynorphin-induced allodynia. Pain 84 (2000) 159-167
22. Ledeboer A., Sloane E.M., Milligan E.D., Frank M.G., Mahony J.H., Maier S.F., et al. Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation. Pain 115 (2005) 71-83
23. Lv R., Zhou W., Chu C., and Xu J. Mechanism of the effect of hydroxyethyl starch on reducing pulmonary capillary permeability in a rat model of sepsis. Annals of Clinical and Laboratory Science 35 (2005) 174-183
24. McQuay H.J., Tramer M., Nye B.A., Carroll D., Wiffen P.J., and Moore R.A. A systematic review of antidepressants in neuropathic pain. Pain 68 (1996) 217-227
25. Merrill J.E., and Benveniste E.N. Cytokines in inflammatory brain lesions: Helpful and harmful. Trends in Neurosciences 19 (1996) 331-338
26. Moore R.Y., and Bloom F.E. Central catecholamine neuron systems: Anatomy and physiology of the norepinephrine and epinephrine systems. Annual Reviews in the Neurosciences 2 (1979) 113-168
27. Nickola T.J., Ignatowski T.A., Reynolds J.L., and Spengler R.N. Antidepressant drug-induced alterations in neuron-localized tumor necrosis factor-a mRNA and a2-adrenergic receptor sensitivity. Journal of Pharmacology and Experimental Therapeutics 297 (2001) 680-687
28. Otsuka N., Kiuchi Y., Yokogawa F., Masuda Y., Oguchi K., and Hosoyamada A. Antinociceptiv efficacy of antidepressants: Assessment of five antidepressants and four monoamine receptors in rats. Journal of Anesthesia 15 (2001) 154-158
29. Proudfit H.K. Pharmacological evidence for the modulation of nociception by noradrenergic neurons. Progress in Brain Research 77 (1988) 357-370
30. Reynolds J.L., Ignatowski T.A., Sud R., and Spengler R.N. An antidepressant mechanism of desipramine is to decrease tumor necrosis factor-alpha production culminating in increases in noradrenergic neurotransmission. Neuroscience 133 (2005) 519-531
31. Richeimer S.H., Bajwa Z.H., Kahraman S.S., Ransil B.J., and Warfield C.A. Utilization patterns of tricyclic antidepressants in a multidisciplinary pain clinic: A survey. Clinical Journal of Pain 13 (1997) 324-329
32. Rogoz Z., Skuza G., and Legutko B. Repeated treatment with mirtazapine induces brain-derived neurotrophic factor gene expression in rats. Journal of Physiology Pharmacology 56 (2005) 661-671
33. Schreiber S., Rigai T., Katz Y., and Pick C.G. The antinociceptive effect of mirtazapine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms. Brain Research Bulletin 58 (2002) 601-605
34. Sud R., Ignatowski T.A., Crystal P.K., and Robert N. Uncovering molecular elements of brain-body communication during development and treatment of neuropathic pain. Brain, Behavior, and Immunity 21 (2007) 112-124
35. Sweitzer S., Martin D., and DeLeo J.A. Intrathecal interleukin-1 receptor antagonist in combination with soluble tumor necrosis factor receptor exhibits an anti-allodynic action in a rat model of neuropathic pain. Neuroscience 103 (2001) 529-539
36. Tura B., and Tura S.M. The analgesic effect of tricyclic antidepressants. Brain Research 51 (1990) 819-822
37. Watkins L.R., Maier S.F., and Goehler L.E. Immune activation: The role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 63 (1995) 289-302
38. Watkins L.R., Milligan E.D., and Maier S.F. Glial activation: A driving force for pathological pain. Trends in Neurosciences 24 (2001) 450-455
39. Watkins L.R., Milligan E.D., and Maier S.F. Glial proinflammatory cytokines mediate exaggerated pain states: Implications for clinical pain. Advances in Experimental Medicine and Biology 521 (2003) 1-21
40. Wieseler-Frank J., Maier S.F., and Watkins L.R. Glial activation and pathological pain. Neurochemistry International 45 (2004) 389-395
41. Zhu J., Wei X., Feng X., Song J., Hu Y., and Xu J. Repeated administration of mirtazapine inhibits development of hyperalgesia/allodynia and activation of NF-kappaB in a rat model of neuropathic pain. Neuroscience Letters 433 1 (2008) 33-37